alosetron has been researched along with Aging in 1 studies
alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, KM | 1 |
| Corrigan, BW | 1 |
| Manzo, J | 1 |
| James, CD | 1 |
| Scott, RJ | 1 |
| Stead, AG | 1 |
| Kersey, KE | 1 |
1 trial available for alosetron and Aging
| Article | Year |
|---|---|
Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors.
Topics: Administration, Oral; Adult; Aging; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Arylamine N-Ace | 2004 |